Literature DB >> 1744143

Thromboxane A2 synthase. Modification during "suicide" inactivation.

D A Jones1, F A Fitzpatrick.   

Abstract

Thromboxane synthase is a ferrihemoprotein which undergoes mechanism-based inactivation during catalysis. This "suicide" process may be an important factor for limiting thromboxane A2 biosynthesis in cells. Although the kinetics have been characterized for purified enzyme and platelets, the chemical basis for inactivation has remained unclear. Protein modification or alteration of the heme prosthetic group is each compatible with the irreversible nature of suicide inactivation of thromboxane synthase. We have investigated these two possibilities using enzyme purified to homogeneity. Our data show that the Soret absorbance spectrum of thromboxane synthase is unaltered by additions of prostaglandin endoperoxide H2 which cause enzymatic inactivation. Using a coupled cyclooxygenase/thromboxane synthase system and polyacrylamide gel electrophoresis we have demonstrated that the enzyme retains radiolabel under nondenaturing gel conditions. Label incorporation is reduced by the competitive thromboxane synthase inhibitor U63557, an agent that also protects the enzyme from inactivation. Under denaturing conditions the radiolabel localizes with the released heme prosthetic group. In addition, interaction of the heme prosthetic group with cyanide was prevented by inactivating the enzyme with prostaglandin H2. In similar experiments, the lipid hydroperoxide 15(S)-hydroperoxyeicosatetraenoic acid inactivated thromboxane synthase with concurrent bleaching of the Soret spectrum. Labeling studies with a coupled soybean lipoxygenase/thromboxane synthase system indicate that, in this case, the apoenzyme is modified. These results suggest that the mechanism of thromboxane synthase inactivation during thromboxane A2 biosynthesis involves a tight, nondestructive association of substrate or product with the prosthetic heme group. Inactivation by hydroperoxides, however, appears to result from apoenzyme modification. These reactions may have important implications for cellular physiology and pathophysiology of thrombosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744143

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population.

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Saori Kawauchi; Shoko Higuchi; Chie Ogawa; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-04-29       Impact factor: 3.172

2.  Multiple factors regulating the expression of human thromboxane synthase gene.

Authors:  K D Lee; S J Baek; R F Shen
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 3.  Extracellular vesicles and their content in bioactive lipid mediators: more than a sack of microRNA.

Authors:  Eric Boilard
Journal:  J Lipid Res       Date:  2018-04-20       Impact factor: 5.922

Review 4.  Eicosanoids: Atherosclerosis and cardiometabolic health.

Authors:  Kimberly Piper; Mahdi Garelnabi
Journal:  J Clin Transl Endocrinol       Date:  2020-02-03

5.  Genome-Wide Analysis Indicates a Complete Prostaglandin Pathway from Synthesis to Inactivation in Pacific White Shrimp, Litopenaeus vannamei.

Authors:  Hao Yang; Xiaoli Chen; Zhi Li; Xugan Wu; Mingyu Zhou; Xin Zhang; Yujie Liu; Yuying Sun; Chunhua Zhu; Qiuhui Guo; Ting Chen; Jiquan Zhang
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

6.  Activity of sEH and Oxidant Status during Systemic Bovine Coliform Mastitis.

Authors:  Vengai Mavangira; Matthew J Kuhn; Angel Abuelo; Christophe Morisseau; Bruce D Hammock; Lorraine M Sordillo
Journal:  Antioxidants (Basel)       Date:  2021-05-20

Review 7.  The enzymology of the human prostanoid pathway.

Authors:  Roger Gregory Biringer
Journal:  Mol Biol Rep       Date:  2020-05-19       Impact factor: 2.316

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.